FDA, EU authorities update guidance on clinical trials during Covid-19
The EMA on Tuesday updated their guidance on managing clinical trials during the Covid-19 pandemic, adding advice on distribution, data verification and communicating with authorities …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.